Supporting Your Loved One in a Clinical Trial

Supporting Your Loved One in a Clinical Trial

The Caregiver’s Role in Clinical Trials

Supporting a loved one in a clincal trial

As a caregiver, your caregiver role in clinical trials is essential for successful participation. You’ll help find suitable trials, monitor side effects, ensure medication compliance, and transport your loved one to appointments. Your caregiver responsibilities in clinical trials include being the primary observer of physical and cognitive changes throughout the study.

Key Insight: Clinical trial participation for caregivers means you become an integral part of the research team, not just a support person.

Why Participate in Clinical Trials?

Families choose clinical trials for multiple reasons. Many want to contribute to scientific advancement and help future patients. Others seek access to cutting-edge treatments not yet available to the public.

Pros & Cons

10 steps to Expect

Myth Busters

Background Information

Featured Clinical Trials

Pros & Cons

PROS:

Access to medical professionals specializing in your loved one’s disease/condition.

Access to cutting edge research and medications not yet available to the public.

Your loved one’s participation increases your knowledge about their disease/condition.

CONS:

The treatment/drug may not work or your loved one may experience some side effects.

Depending on the phase of the trial, your loved one may be given a placebo instead of the actual drug.

Depending on the study, you and your loved one may be required to make a lot of visits, appointments, and possible hospital stays.

Understanding the pros and cons of participating in clinical trials is crucial.

The benefits of clinical trials include access to innovative treatments, comprehensive medical monitoring, and additional support from specialized research staff. Participants often receive more frequent medical attention and detailed health assessments than standard care provides.

Potential drawbacks include time commitments, travel requirements, possible side effects, and the uncertainty that comes with experimental treatments. Some participants may receive placebo treatments rather than active medication.

Remember: Supporting loved one in clinical trials requires careful consideration of both benefits and challenges. Discuss thoroughly with your healthcare team before making this important decision.

10 Steps to Expect

  • Identify possible Clinical Trials
  • Consult with your loved one’s doctor to see if he/she thinks participation in a trial is an option and if it could help them.
  • Determine if your loved one is eligible to participate in a particular trial.
  • Enroll in the trial.
  • Educate yourself on the drug or treatment protocol.
  • Learn what will be required.
  • Fill out and sign all the necessary paperwork.
  • Think about transportation to medical visits specific to the clinical trial—this may include facilities other than your loved one’s usual doctor, additional appointments, additional lab work, imaging, etc.
  • Comply with the treatment plan including:
  • Administering medication
  • Monitoring your loved one’s condition
  • Reporting to the organizers of the trial as required
  • Following the schedule of doctor or treatment visits—which vary by trial. Follow up visits could be weekly, monthly, or yearly and may change as the trial progresses.
  • Coordinate how to keep your loved one’s care team informed of any side effects, changes in your loved one’s condition or abilities, and concerns you have.

The Myths About Clinical Trials

Before a drug can be approved for use, it undergoes rigorous screening and preclinical testing. This process ensures its safety and effectiveness. Before a clinical trial can begin, researchers typically conduct years of testing. The entire process can take up to six years to complete.Additionally, every clinical trial includes a thorough informed consent process. This process ensures that you and your loved ones understand what participating involves. It also covers any side effects experienced by previous participants. Participants are also able to leave the trial at any time and for any reason.

Some clinical trials measure the effectiveness of a potential new drug or treatment against a placebo. A placebo is an inactive substance or treatment used as a control. However, placebos aren’t used in every trial. Some other trials test a potential new drug or treatment against the existing standard of care. The decision to use a placebo in a clinical trial depends on several factors. These include the seriousness of the illness and the availability of existing treatments. Ethical standards also play a crucial role in this decision-making process. For serious or life-threatening diseases, the best available treatment is used instead of a placebo.

Because clinical trials are done for research purposes, there is some level of risk. However, the drugs being studied are given to clinical trial participants only after the drugs have gone through a rigorous testing process and scientific evidence indicates that the drug is likely to be effective and safe for use in humans. The safety of the patients is a top priority for everyone involved in the trial. Before a clinical trial can even begin, it’s reviewed by an institutional review board (IRB)—a committee of doctors, scientists, and community members who have the responsibility to protect clinical trial participants. This review makes sure that both before and during the trial, steps are taken to protect the rights and safety of the trial participants. During the clinical trial, the safety of participants is closely monitored.

The amount of time required to participate in a clinical trial varies widely. For some, your loved one may only need to make a few visits every couple of months. Others may require weekly visits. Some trials require overnight visits. Before your loved one enrolls in a trial, the trial schedule will be explained and you will have an opportunity to ask questions or share any concerns that you have.

Costs related to participating in a clinical trial are rarely required to be paid by participants. The sponsor of the study covers research costs. Patient care costs that sponsors do not cover are often covered by the patient’s health insurance carrier. Before enrolling in a clinical trial, ask the research team about the costs your loved one would be expected to pay, and then check with your loved one’s health insurance carrier to see if they will cover it.

Participants in a clinical trial may have access to an investigational drug that is not yet available to people outside of the trial. Participants are closely monitored by clinical trial researchers—maybe even more closely than their regular doctor. Depending on the clinical trial treatment plan (or protocol), participants may receive additional tests and lab work that are outside of their usual care.

Regional hospitals and smaller research facilities also run clinical trials. In addition, some clinical trials—particularly those for rare diseases—offer compensation for any patients who need to travel in order to participate.

While participating in a clinical trial can be an option for patients who tried the other options without success, there are clinical trials for patients at all different stages of their diagnosis. Some trials that target newly-diagnosed patients. Others may recruit patients who exhibit specific symptoms or who were diagnosed many years ago.

Background Information

According to the National Institutes of Health (NIH), the goal of clinical trials is to determine if a new treatment—such as a new drug or medical device—prevention, or behavior approach is safe and effective. Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment.

Another type of clinical trial tests ways to find a disease early, sometimes before there are symptoms. Others test ways to prevent a health problem. A clinical trial may look at how to make life better for people living with a life-threatening disease or a chronic health problem. There are even clinical trials to study the role of family caregivers or support groups.

Before the U.S. Food and Drug Administration (FDA) will approve the start of a clinical trial, laboratory tests have been performed to test a potential therapy’s safety and efficacy. If these studies show favorable results, the FDA gives approval for the intervention to be tested on people.

Clinical trials advance through four phases to test a treatment, find the appropriate dosage, and look for side effects. After the first three phases, if researchers find a drug or other intervention to be safe and effective, the FDA approves it for clinical use and continues to monitor its effects.

Phase 1:
20-100 healthy volunteers or people with the disease/condition being studied. The purpose is to study the safety and determine the proper dosage. This phase lasts several months. The FDA reports that 70% of new drugs move to the next phase.

Phase 2:
Up to several hundred people with the disease/condition. The purpose is to determine the short-term safety and efficacy and to see if there are any side effects. A small group is given a placebo for comparison. This phase lasts from several months to 2 years. The FDA reports that 33% of drugs move to the next phase.

Phase 3:
300-3,000 people with the disease/condition. The purpose is to further study the efficacy, look out for any adverse reactions, and compare the new drug with other treatments (another drug or placebo). This phase lasts 1-4 years. Because this phase is larger and longer, side effects that take a while to appear or are rare, are more likely to be seen. The FDA reports only 25-30% of drugs move to the next phase.

Phase 4:
Several thousand people who have the disease/condition. The purpose is to further study the efficacy and safety.